Frenette C - Search Results

1

Liver transplantation for hepatocellular carcinoma: Management after the transplant.

Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY. Verna EC, et al. Among authors: frenette c. Am J Transplant. 2020 Feb;20(2):333-347. doi: 10.1111/ajt.15697. Epub 2019 Dec 9. Am J Transplant. 2020. PMID: 31710773 Free article. Review.

2

Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib.

Frenette CT, Frederick RT, Gish RG. Frenette CT, et al. J Clin Gastroenterol. 2011 Sep;45(8):733-7. doi: 10.1097/MCG.0b013e3181f68e83. J Clin Gastroenterol. 2011. PMID: 20930642

3

Pre-transplant utilization of sorafenib is not associated with increased complications after liver transplantation.

Frenette CT, Boktour M, Burroughs SG, Kaseb A, Aloia TA, Galati J, Gaber AO, Monsour H Jr, Ghobrial RM. Frenette CT, et al. Transpl Int. 2013 Jul;26(7):734-9. doi: 10.1111/tri.12117. Epub 2013 May 23. Transpl Int. 2013. PMID: 23701126 Free article.

4

Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response.

Frenette CT, Osorio RC, Stark J, Fok B, Boktour MR, Guy J, Rhee J, Osorio RW. Frenette CT, et al. Transplantation. 2014 Oct 15;98(7):781-7. doi: 10.1097/TP.0000000000000121. Transplantation. 2014. PMID: 24825513

5

Current management of hepatocellular carcinoma.

Crissien AM, Frenette C. Crissien AM, et al. Among authors: frenette c. Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61. Gastroenterol Hepatol (N Y). 2014. PMID: 24829542 Free PMC article.

6

Building the multidisciplinary team for management of patients with hepatocellular carcinoma.

Naugler WE, Alsina AE, Frenette CT, Rossaro L, Sellers MT. Naugler WE, et al. Clin Gastroenterol Hepatol. 2015 May;13(5):827-35. doi: 10.1016/j.cgh.2014.03.038. Epub 2014 Jun 5. Clin Gastroenterol Hepatol. 2015. PMID: 24909910 Free PMC article. Review.

7

Management of Hepatocellular Carcinoma: Current Status and Future Directions.

Au JS, Frenette CT. Au JS, et al. Gut Liver. 2015 Jul;9(4):437-48. doi: 10.5009/gnl15022. Gut Liver. 2015. PMID: 26087860 Free PMC article. Review.

8

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

Brown RS Jr, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR Jr, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA; Hepatitis C Therapeutic Registry Research Network Study Group. Brown RS Jr, et al. Among authors: frenette ct. Liver Transpl. 2016 Jan;22(1):24-33. doi: 10.1002/lt.24366. Liver Transpl. 2016. PMID: 26519873 Free PMC article.

9

Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.

Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Ha J, et al. J Clin Gastroenterol. 2016 May-Jun;50(5):423-30. doi: 10.1097/MCG.0000000000000448. J Clin Gastroenterol. 2016. PMID: 26583267

10

Surveillance for hepatocellular carcinoma.

Frenette C. Frenette C. Clin Adv Hematol Oncol. 2016 Jun;14(6):407-9. Clin Adv Hematol Oncol. 2016. PMID: 27379808 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters